IPO - EZZ Life Science Holdings Limited - 26 February 2021 #, page-123

Check out the companies Tmall page selling direct to China.
the new product only recently introduced - EZZ NMN 150000
appears to be doing very well. This is the kind of proprietary product that is going to propel EZZ’s position away from Eoaron’s distribution business and focus on proprietary manufacturing providing a better valuation.

There are 4 pillars to any business - product, region, distribution & aquisition. To me EZZ is doing well in 2 pillars - Product & Distribution expansion. The real reward is going to come when the expansion happens to other regions like Europe or Japan....

this is a great potential in play for EZZ. Hang in there for multibagging.